AGENUS INC Cash Acquired from Acquisition
AGENUS INC (AGEN) reported Cash Acquired from Acquisition of $28.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Cash Flow
us-gaap:CashAcquiredFromAcquisition · last filed 2020-08-10
- AGENUS INC cash acquired from acquisition for the quarter ending 2015-09-30 was $0.00.
- AGENUS INC cash acquired from acquisition for the quarter ending 2015-06-30 was $0.00.
- AGENUS INC cash acquired from acquisition for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC cash acquired from acquisition for the quarter ending 2014-12-31 was $0.00.
- AGENUS INC cash acquired from acquisition for fiscal 2014 was $514.47K.
- AGENUS INC cash acquired from acquisition for fiscal 2013 was $0.00.
- AGENUS INC cash acquired from acquisition for fiscal 2012 was $0.00.
| Period end | Cash Acquired from Acquisition 3 month | Cash Acquired from Acquisition 6 month | Cash Acquired from Acquisition 9 month | Cash Acquired from Acquisition 12 month |
|---|---|---|---|---|
| 2020-06-30 | $28.00K 10-Q · filed 2020-08-10 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | $0.00 derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $0.00 10-Q · filed 2015-08-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $514.47K 10-K · filed 2017-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $514.47K 10-Q · filed 2015-11-04 | $514.47K derived: sum of 4 quarters · filed 2015-11-04 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $514.47K 10-Q · filed 2015-08-03 | $514.47K derived: sum of 3 quarters · filed 2015-08-03 | |
| 2014-03-31 | $514.47K 10-Q · filed 2015-05-01 | $514.47K derived: sum of 2 quarters · filed 2015-05-01 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-31 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |